Introduction to Policy Engagement in Polio Eradication

Anna Kalbarczyk, DrPH, MPH Bloomberg School of Public Health, Johns Hopkins University, USA

In the lecture, Dr. Kalbarczyk highlights the need to engage a diverse group of stakeholders in a global disease control program, as well as the importance of advocacy at every level of government.

Now, consider your own policy setting. If you are to implement a disease control program who do you think are key stakeholders to engage? Why are they important? What might the best ways to actively engage them?

Post your responses in the discussion section.